Search

everythinglearnresearchcommunity

for

Search:↓

Women with androgenetic alopecia have fewer terminal hairs, phenol in nail surgery is safe, and a new hair transplant method is faster and less damaging.

Hyperpigmentation is common in pregnancy and may not fully fade after birth; melasma, also frequent, can persist but has limited treatment options during pregnancy.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

The document suggests a bacteria plays a significant role in acne rosacea and that white hair can regain color after transplant, meriting more research on reversing grey hair.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Melatonin directly affects mouse hair follicles and may influence hair growth.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

Lasers are effective and safe for various medical treatments, including cancer, wound healing, and skin conditions.

Some chemicals can permanently or temporarily remove color from skin and hair, which can be distressing and is not well-regulated in cosmetics.

Dermal stem cells help regenerate hair follicles and heal skin wounds.

Cyclosporin doesn't stop hair loss.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Vitiligo often starts young, is linked to family history and stress, and requires comprehensive care including psychological support.

The Peripilar sign does not indicate perifollicular infiltrate in hair loss from Androgenetic Alopecia.

Premature hair graying in the face may be influenced by genetics and environment.

Researchers successfully isolated and identified key markers of stem cell-enriched human hair follicle bulge cells.

PPARγ is crucial for skin health but can have both beneficial and harmful effects.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Hair is important for protection, social interaction, and temperature control, and is made of a growth cycle-influenced follicle and a complex shaft.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

ALRN-6924 may prevent hair loss caused by chemotherapy.

CD34+ hair follicle stem cells can become melanin-producing cells for treating skin conditions.

taVNS reduces vitiligo symptoms in mice.

Korean Red Ginseng may help protect hair from damage and promote growth.

Removing hair from mice without reproductive glands led to grey hair, possibly helping to understand greying in aging.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

We now understand more about what causes acne and this could lead to better, more personalized treatments.

Skin stem cells interacting with their environment is crucial for maintaining and regenerating skin and hair, and understanding this can help develop new treatments for skin and hair disorders.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.